Schuemie.net

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Authors' Reply to Hennessy and Leonard's Comment on "Desideratum for Evidence-Based Epidemiology". Drug Saf 2014

Patadia VK, Schuemie MJ, Coloma P, Herings R, van der Lei J, Straus S, Sturkenboom M, Trifiro G. Evaluating performance of electronic healthcare records and spontaneous reporting data in drug safety signal detection. Int J Clin Pharm 2014

Patadia VK, Coloma P, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Fornari C, Pedersen L, van der Lei J, Sturkenboom M, Trifiro G. Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project. Expert Rev Clin Pharmacol 2015;8(1):95-102

Afzal Z, Pons E, Kang N, Sturkenboom M, Schuemie MJ, Kors JA. ContextD: an algorithm to identify contextual properties of medical terms in a Dutch clinical corpus. BMC Bioinformatics 2014;15(1):373

Vilar S, Ryan PB, Madigan D, Stang PE, Schuemie MJ, Friedman C, Tatonetti NP, Hripcsak G. Similarity-based modeling applied to signal detection in pharmacovigilance. CPT Pharmacometrics Syst Pharmacol 2014;3:e137

Boyce RD, Ryan PB, Noren GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifiro G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, Dumontier M. Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest. Drug Saf 2014;37(8):557-67

Masclee GM, Valkhoff VE, Coloma PM, de Ridder M, Romio S, Schuemie MJ, Herings R, Gini R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, Kuipers EJ, van der Lei J, Sturkenboom MC. Risk of upper gastrointestinal bleeding from different drug combinations. Gastroenterology 2014;147(4):784-792 e9; quiz e13-4

Gini R, Schuemie MJ, Francesconi P, Lapi F, Cricelli I, Pasqua A, Gallina P, Donato D, Brugaletta S, Donatini A, Marini A, Cricelli C, Damiani G, Bellentani M, van der Lei J, Sturkenboom MC, Klazinga NS. Can Italian healthcare administrative databases be used to compare regions with respect to compliance with standards of care for chronic diseases?. PLoS One 2014;9(5):e95419

Valkhoff VE, Coloma PM, Masclee GM, Gini R, Innocenti F, Lapi F, Molokhia M, Mosseveld M, Nielsson MS, Schuemie M, Thiessard F, van der Lei J, Sturkenboom MC, Trifiro G. Validation study in four health-care databases: upper gastrointestinal bleeding misclassification affects precision but not magnitude of drug-related upper gastrointestinal bleeding risk. J Clin Epidemiol 2014;67(8):921-31

Schuemie MJ, Trifiro G, Coloma PM, Ryan PB, Madigan D. Detecting adverse drug reactions following long-term exposure in longitudinal observational data: The exposure-adjusted self-controlled case series. Stat Methods Med Res 2014

Trifiro G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?. J Intern Med 2014;275(6):551-61

Ryan PB, Madigan D, Stang PE, Schuemie MJ, Hripcsak G. Medication-wide association studies. CPT Pharmacometrics Syst Pharmacol 2013;2:e76

Ferrajolo C, Coloma PM, Verhamme KM, Schuemie MJ, de Bie S, Gini R, Herings R, Mazzaglia G, Picelli G, Giaquinto C, Scotti L, Avillach P, Pedersen L, Rossi F, Capuano A, van der Lei J, Trifiro G, Sturkenboom MC. Signal detection of potentially drug-induced acute liver injury in children using a multi-country healthcare database network. Drug Saf 2014;37(2):99-108

Romio S, Webel D, Dieleman JP, Olberg HK, de Vries CS, Sammon C, Andrews N, Svanstrom H, Molgaard-Nielsen D, Hviid A, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim-Dahlstrom L, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs BC, Leino T, Kilpi T, Storsaeter J, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. Guillain-Barre Syndrome and Adjuvanted Pandemic Influenza A (H1N1) 2009 Vaccines: A Multinational Self-Controlled Case Series in Europe. PLoS One 2014;9(1):e82222

Geissbuhler A, Hammond WE, Hasman A, Hussein R, Koppel R, Kulikowski CA, Maojo V, Martin-Sanchez F, Moorman PW, Moura LA, de Quiros FG, Schuemie MJ, Smith B, Talmon J. Discussion of "biomedical informatics: we are what we publish". Methods Inf Med 2013;52(6):547-62

Ryan P, Suchard MA, Schuemie M, Madigan D. Learning From Epidemiology: Interpreting Observational Database Studies for the Effects of Medical Products. Statistics in Biopharmaceutical Research 2013;5(3):170-179

Valkhoff VE, Schade R, t Jong GW, Romio S, Schuemie MJ, Arfe A, Garbe E, Herings R, Lucchi S, Picelli G, Schink T, Straatman H, Villa M, Kuipers EJ, Sturkenboom MC. Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?. BMC Pediatr 2013;13:192

Dumouchel W, Ryan PB, Schuemie MJ, Madigan D. Evaluation of disproportionality safety signaling applied to healthcare databases. Drug Saf 2013;36 Suppl 1:123-32

Madigan D, Schuemie MJ, Ryan PB. Empirical performance of the case-control method: lessons for developing a risk identification and analysis system. Drug Saf 2013;36 Suppl 1:73-82

Noren GN, Bergvall T, Ryan PB, Juhlin K, Schuemie MJ, Madigan D. Empirical performance of the calibrated self-controlled cohort analysis within temporal pattern discovery: lessons for developing a risk identification and analysis system. Drug Saf 2013;36 Suppl 1:107-21

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Desideratum for evidence based epidemiology. Drug Saf 2013;36 Suppl 1:5-14

Reich CG, Ryan PB, Schuemie MJ. Alternative outcome definitions and their effect on the performance of methods for observational outcome studies. Drug Saf 2013;36 Suppl 1:181-93

Ryan PB, Schuemie MJ. Evaluating performance of risk identification methods through a large-scale simulation of observational data. Drug Saf 2013;36 Suppl 1:171-80

Ryan PB, Schuemie MJ, Gruber S, Zorych I, Madigan D. Empirical performance of a new user cohort method: lessons for developing a risk identification and analysis system. Drug Saf 2013;36 Suppl 1:59-72

Ryan PB, Schuemie MJ, Madigan D. Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis system. Drug Saf 2013;36 Suppl 1:95-106

Ryan PB, Schuemie MJ, Welebob E, Duke J, Valentine S, Hartzema AG. Defining a reference set to support methodological research in drug safety. Drug Saf 2013;36 Suppl 1:33-47

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, Dumouchel W, Reich CG, Schuemie MJ, Madigan D. A comparison of the empirical performance of methods for a risk identification system. Drug Saf 2013;36 Suppl 1:143-58

Schuemie MJ, Gini R, Coloma PM, Straatman H, Herings RM, Pedersen L, Innocenti F, Mazzaglia G, Picelli G, van der Lei J, Sturkenboom MC. Replication of the OMOP Experiment in Europe: Evaluating Methods for Risk Identification in Electronic Health Record Databases. Drug Saf 2013;36 Suppl 1:159-69

Schuemie MJ, Madigan D, Ryan PB. Empirical Performance of LGPS and LEOPARD: Lessons for Developing a Risk Identification and Analysis System. Drug Saf 2013;36 Suppl 1:133-42

Schuemie MJ, Ryan PB, Suchard MA, Shahn Z, Madigan D. Discussion: An estimate of the science-wise false discovery rate and application to the top medical literature. Biostatistics 2013

Simpson SE, Madigan D, Zorych I, Schuemie MJ, Ryan PB, Suchard MA. Multiple self-controlled case series for large-scale longitudinal observational databases. Biometrics 2013

Stang PE, Ryan PB, Overhage JM, Schuemie MJ, Hartzema AG, Welebob E. Variation in Choice of Study Design: Findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) Survey. Drug Saf 2013;36 Suppl 1:15-25

Suchard MA, Zorych I, Simpson SE, Schuemie MJ, Ryan PB, Madigan D. Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis system. Drug Saf 2013;36 Suppl 1:83-93

Yoon D, Park I, Schuemie MJ, Park MY, Kim JH, Park RW. A quantitative method for assessment of prescribing patterns using electronic health records. PLoS One 2013;8(10):e75214

Coloma PM, Schuemie MJ, Trifiro G, Furlong L, van Mulligen E, Bauer-Mehren A, Avillach P, Kors J, Sanz F, Mestres J, Oliveira JL, Boyer S, Helgee EA, Molokhia M, Matthews J, Prieto-Merino D, Gini R, Herings R, Mazzaglia G, Picelli G, Scotti L, Pedersen L, van der Lei J, Sturkenboom M. Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system. PLoS One 2013;8(8):e72148

Schuemie MJ, Ryan PB, Dumouchel W, Suchard MA, Madigan D. Interpreting observational studies: why empirical calibration is needed to correct p-values. Statistics in Medicine 2013

Dodd CN, Romio SA, Black S, Vellozzi C, Andrews N, Sturkenboom M, Zuber P, Hua W, Bonhoeffer J, Buttery J, Crawford N, Deceuninck G, de Vries C, De Wals P, Gutierrez-Gimeno MV, Heijbel H, Hughes H, Hur K, Hviid A, Kelman J, Kilpi T, Chuang SK, Macartney K, Rett M, Lopez-Callada VR, Salmon D, Gimenez-Sanchez F, Sanz N, Silverman B, Storsaeter J, Thirugnanam U, van der Maas N, Yih K, Zhang T, Izurieta H. International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013;31(40):4448-58

Coloma PM, Valkhoff VE, Mazzaglia G, Nielsson MS, Pedersen L, Molokhia M, Mosseveld M, Morabito P, Schuemie MJ, van der Lei J, Sturkenboom M, Trifiro G. Identification of acute myocardial infarction from electronic healthcare records using different disease coding systems: a validation study in three European countries. BMJ Open 2013;3(6)

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, Dumouchel W, Berlin JA. Evaluating the Impact of Database Heterogeneity on Observational Study Results. American Journal of Epidemioly 2013

Madigan D, Ryan PB, Schuemie M. Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies. Therapeutic Advances in Drug Safety 2013;4(2):53-62

Afzal Z, Engelkes M, Verhamme KM, Janssens HM, Sturkenboom MC, Kors JA, Schuemie MJ. Automatic generation of case-detection algorithms to identify children with asthma from large electronic health record databases. Pharmacoepidemiology & Drug Safety 2013

Ferrajolo C, Verhamme KM, Trifiro G, t Jong GW, Giaquinto C, Picelli G, Oteri A, de Bie S, Valkhoff VE, Schuemie MJ, Mazzaglia G, Cricelli C, Rossi F, Capuano A, Sturkenboom MC. Idiopathic Acute Liver Injury in Paediatric Outpatients: Incidence and Signal Detection in Two European Countries. Drug Safety 2013

Afzal Z, Schuemie MJ, van Blijderveen JC, Sen EF, Sturkenboom MC, Kors JA. Improving sensitivity of machine learning methods for automated case identification from free-text electronic medical records. BMC Medical Informatics & Decision Making 2013;13:30

Gini R, Francesconi P, Mazzaglia G, Cricelli I, Pasqua A, Gallina P, Brugaletta S, Donato D, Donatini A, Marini A, Zocchetti C, Cricelli C, Damiani G, Bellentani M, Sturkenboom MC, Schuemie MJ. Chronic disease prevalence from Italian administrative databases in the VALORE project: a validation through comparison of population estimates with general practice databases and national survey. BMC Public Health 2013;13(1):15

Coloma PM, Avillach P, Salvo F, Schuemie MJ, Ferrajolo C, Pariente A, Fourrier-Reglat A, Molokhia M, Patadia V, van der Lei J, Sturkenboom M, Trifiro G. A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases. Drug Safety 2013;36(1):13-23

Wijnans L, Lecomte C, de Vries C, Weibel D, Sammon C, Hviid A, Svanstrom H, Molgaard-Nielsen D, Heijbel H, Dahlstrom LA, Hallgren J, Sparen P, Jennum P, Mosseveld M, Schuemie M, van der Maas N, Partinen M, Romio S, Trotta F, Santuccio C, Menna A, Plazzi G, Moghadam KK, Ferro S, Lammers GJ, Overeem S, Johansen K, Kramarz P, Bonhoeffer J, Sturkenboom MC. The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2012

Schuemie MJ, Sen E, t Jong GW, van Soest EM, Sturkenboom MC, Kors JA. Automating classification of free-text electronic health records for epidemiological studies. Pharmacoepidemiology & Drug Safety 2012;21(6):651-8

Schuemie MJ, Coloma PM, Straatman H, Herings RM, Trifiro G, Matthews JN, Prieto-Merino D, Molokhia M, Pedersen L, Gini R, Innocenti F, Mazzaglia G, Picelli G, Scotti L, van der Lei J, Sturkenboom MC. Using Electronic Health Care Records for Drug Safety Signal Detection: A Comparative Evaluation of Statistical Methods. Medical Care 2012;50(10):890-897

Schuemie MJ. Safety surveillance of longitudinal databases: further methodological considerations. Pharmacoepidemiology & Drug Safety 2012;21(6):670-2

Loiacono C, Sgroi C, Coppolino S, Cannata A, Ferrara R, Arcoraci V, Cananzi P, Savica V, Schuemie MJ, Caputi AP, Trifiro G. How much are biosimilars used in southern Italy?: a retrospective analysis of epoetin utilization in the local health unit of Messina in the years 2010-2011. BioDrugs 2012;26(2):113-20

Leal I, Romio SA, Schuemie M, Oteri A, Sturkenboom M, Trifiro G. Prescribing pattern of glucose lowering drugs in The United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone. British Journal of Clinical Pharmacology 2012

Coloma PM, Trifiro G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M. Electronic healthcare databases for active drug safety surveillance: is there enough leverage?. Pharmacoepidemiology & Drug Safety 2012;21(6):611-621

Avillach P, Coloma PM, Gini R, Schuemie M, Mougin F, Dufour JC, Mazzaglia G, Giaquinto C, Fornari C, Herings R, Molokhia M, Pedersen L, Fourrier-Reglat A, Fieschi M, Sturkenboom M, van der Lei J, Pariente A, Trifiro G. Harmonization process for the identification of medical events in eight European healthcare databases: the experience from the EU-ADR project. Journal of the American Medical Informatics Association 2012

Andrews N, Stowe J, Miller E, Svanstrom H, Johansen K, Bonhoeffer J, Hviid A. A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark. Vaccine 2012;30(19):3042-6

van Haagen HH, t Hoen PA, de Morree A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ. In silico discovery and experimental validation of new protein-protein interactions. Proteomics 2011;11(5):843-53

Trifiro G, Patadia V, Schuemie MJ, Coloma PM, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Scotti L, Pedersen L, Avillach P, Sturkenboom MC, van der Lei J, Eu-Adr G. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Studies in Health Technology & Informatics 2011;166:25-30

Schuemie MJ. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD. Pharmacoepidemiology & Drug Safety 2011;20(3):292-9

Schuemie M, Trieschnigg D, Meij E. DutchHatTrick: Semantic query modeling, ConText, section detection, and match score maximization. Proceedings of the 2011 Text REtrieval Conference (TREC 2011) Gaithersburg, MD;2011

Jelier R, Goeman JJ, Hettne KM, Schuemie MJ, den Dunnen JT, t Hoen PA. Literature-aided interpretation of gene expression data with the weighted global test. Briefings in Bioinformatics 2011;12(5):518-29

Dieleman J, Romio S, de Vries C, Sammon C, Andrews N, Hviid A, Svanström H, Mølgaard-Nielsen D, Lapeyre-Mestre M, Sommet A, Saussier C, Castot A, Heijbel H, Arnheim Dahlström L, Hallgren J, Sparen P, Mosseveld M, Schuemie M, van der Maas N, Jacobs B, Johansen K, Kramarz P, Weibel D, Bonhoeffer J, Sturkenboom M. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. British Medical Journal 2011;343:d3908

Coloma PM, Schuemie MJ, Trifiro G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiology & Drug Safety 2011;20(1):1-11

Schuemie MJ, Kang N, Hekkelman ML, Kors JA. GeneE: gene and protein query expansion with disambiguation. Bioinformatics 2010;26(1):147-8

Hettne KM, van Mulligen EM, Schuemie MJ, Schijvenaars BJ, Kors JA. Rewriting and suppressing UMLS terms for improved biomedical term identification. Journal of Biomedical Semantics 2010;1(1):5

Ferrajolo C, Capuano A, Verhamme KM, Schuemie MJ, Rossi F, Stricker BH, Sturkenboom MC. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. British Journal of Clinincal Pharmacology 2010;70(5):721-8

van Haagen HH, t Hoen PA, Botelho Bovo A, de Morree A, van Mulligen EM, Chichester C, Kors JA, den Dunnen JT, van Ommen GJ, van der Maarel SM, Kern VM, Mons B, Schuemie MJ. Novel protein-protein interactions inferred from literature context. PLoS One 2009;4(11):e7894

Steele E, Tucker A, t Hoen PA, Schuemie MJ. Literature-based priors for gene regulatory networks. Bioinformatics 2009;25(14):1768-74

Schuemie MJ, Talmon JL, Moorman PW, Kors JA. Mapping the domain of medical informatics. Methods of Information in Medicine 2009;48(1):76-83

Roos M, Marshall MS, Gibson AP, Schuemie MJ, Meij E, Katrenko S, van Hage WR, Krommydas K, Adriaans PW. Structuring and extracting knowledge for the support of hypothesis generation in molecular biology. BMC Bioinformatics 2009;10 Suppl 10:S9

Moorman PW, Schuemie MJ, van der Lei J. An inventory of publications on electronic medical records revisited. Methods of Information in Medicine 2009;48(5):454-8

Hettne KM, Stierum RH, Schuemie MJ, Hendriksen PJ, Schijvenaars BJ, Mulligen EM, Kleinjans J, Kors JA. A dictionary to identify small molecules and drugs in free text. Bioinformatics 2009;25(22):2983-91

Schuemie MJ, Kors JA. Jane: suggesting journals, finding experts. Bioinformatics 2008;24(5):727-8

Morgan AA, Lu Z, Wang X, Cohen AM, Fluck J, Ruch P, Divoli A, Fundel K, Leaman R, Hakenberg J, Sun C, Liu HH, Torres R, Krauthammer M, Lau WW, Liu H, Hsu CN, Schuemie MJ, Cohen KB, Hirschman L. Overview of BioCreative II gene normalization. Genome Biology 2008;9 Suppl 2:S3

Jelier R, Schuemie MJ, Veldhoven A, Dorssers LC, Jenster G, Kors JA. Anni 2.0: a multipurpose text-mining tool for the life sciences. Genome Biology 2008;9(6):R96

Jelier R, Schuemie MJ, Roes PJ, van Mulligen EM, Kors JA. Literature-based concept profiles for gene annotation: the issue of weighting. International Journal of Medical Informatics 2008;77(5):354-62

Schuemie MJ, Mons B, Weeber M, Kors JA. Evaluation of techniques for increasing recall in a dictionary approach to gene and protein name identification. Journal of Biomedical Informatics 2007;40(3):316-24

Schuemie MJ, Chichester C, Lisacek F, Coute Y, Roes PJ, Sanchez JC, Kors J, Mons B. Assignment of protein function and discovery of novel nucleolar proteins based on automatic analysis of MEDLINE. Proteomics 2007;7(6):921-31

Schuemie M, Trieschnigg D, Kraaij W. Cross Language Information Retrieval for Biomedical Literature. The Sixteenth Text REtrieval Conference (TREC 2007) Gaithersburg, MD;2007

Schuemie M, Jelier R, Kors JA. Peregrine: Lightweight gene name normalization by dictionary lookup. Proceedings of the Biocreative 2 workshop Madrid, Spain;2007

Krijn M, Emmelkamp PM, Olafsson RP, Schuemie MJ, van der Mast CA. Do self-statements enhance the effectiveness of virtual reality exposure therapy? A comparative evaluation in acrophobia. Cyberpsychology & Behavior 2007;10(3):362-70

Krijn M, Emmelkamp PM, Olafsson RP, Bouwman M, van Gerwen LJ, Spinhoven P, Schuemie MJ, van der Mast CA. Fear of flying treatment methods: virtual reality exposure vs. cognitive behavioral therapy. Aviation, Space, and Environmental Medicine 2007;78(2):121-8

Trieschnigg D, Kraaij W, Schuemie M. Concept Based Document Retrieval for Genomics Literature. The Fifteenth Text REtrieval Conference (TREC 2006) Proceedings Gaithersburg, MD;2006

Schuemie MJ, Kors JA, Mons B. Word sense disambiguation in the biomedical domain: an overview. Journal of Computational Biology 2005;12(5):554-65

Schuemie M, Abel B, van der Mast CAPG, Krijn M, Emmelkamp PMG. The Effect of Locomotion Technique on Presence, Fear, and Usability In a Virtual Environment. Proceedings of the Euromedia 2005 conference Toulouse;2005

Schijvenaars BJ, Mons B, Weeber M, Schuemie MJ, van Mulligen EM, Wain HM, Kors JA. Thesaurus-based disambiguation of gene symbols. BMC Bioinformatics 2005;6:149

Schijvenaars B, Schuemie M, Mulligen EM, Weeber M, Jelier R, Mons B, Kors JA. A Concept-Based Approach to Text Categorization. The Fourteenth Text REtrieval Conference (TREC 2005) Proceedings Gaithersburg, MD;2005

van Mulligen E, Diwersy M, Schijvenaars B, Weeber M, van der Eijk C, Jelier R, Schuemie MJ, Kors J, Mons B. Contextual annotation of web pages for interactive browsing. Studies in Health Technology & Informatics 2004;107(Pt 1):94-8

Schuemie MJ, Weeber M, Schijvenaars BJ, van Mulligen EM, van der Eijk CC, Jelier R, Mons B, Kors JA. Distribution of information in biomedical abstracts and full-text publications. Bioinformatics 2004;20(16):2597-604

Krijn M, Emmelkamp PM, Biemond R, de Wilde de Ligny C, Schuemie MJ, van der Mast CA. Treatment of acrophobia in virtual reality: the role of immersion and presence. Behaviour Research & Therapy 2004;42(2):229-39

Schuemie M. Human-Computer Interaction and Presence in Virtual Reality Exposure Therapy. Delft University of Technology;2003

Schuemie MJ, van den Berg J, Tan RPGH. Self Organizing Maps, a Visual Exploration Tool in Datamining. In: Dealing with the data flood. STT / Beweton;763-770;2002

Schuemie MJ. Exploratory Design and Evaluation of a User Interface for Virtual Reality Exposure Therapy. Medicine Meets Virtual Reality 02/10 Newport Beach, CA;IOS Press;468--474;2002

Schuemie MJ. Effect of an External Viewpoint on Therapist Performance in Virtual Reality Exposure Therapy. CHI2002 Extended Abstracts Minneapolis, Minnesota;ACM Press;834--835;2002

Emmelkamp PM, Krijn M, Hulsbosch AM, de Vries S, Schuemie MJ, van der Mast CA. Virtual reality treatment versus exposure in vivo: a comparative evaluation in acrophobia. Behaviour Research & Therapy 2002;40(5):509-16

Schuemie MJ, van der Straaten P, Krijn M, van der Mast CA. Research on presence in virtual reality: a survey. Cyberpsychology & Behavior 2001;4(2):183-201

Schuemie MJ, van der Mast CAPG. VR Testbed Configuration for Phobia Treatment Research. Proceedings of the Euromedia 2001 Conference Valencia, Spain;200--204;2001

Schuemie MJ, Bruynzeel M, Drost L, Brinckman. Treatment of acrophobia in virtual reality: A pilot study. Conference Proceedings Euromedia 2000 Antwerp, Belgium;271--275;2000

Schuemie MJ. Design of Virtual Reality Exposure Therapy Systems - Task Analysis. Chi 2000 Extended Abstracts;ACM press;345--346;2000

Schuemie M, van der Mast CAPG. Virtual Reality in de Therapie. Proceedings of the Revalidatie Anno 2000 Conference Nederlands Instituut voor Psychologen;2000

van den Berg J, Schuemie MJ. Information retrieval systems using an associative conceptual space. Proceedings of the 7th European Symposium on Artificial Neural Networks (ESANN’99);D-Facto Publishing;351--356;1999

Schuemie MJ, van der Mast CAPG. Presence: Interacting in VR?. Proceedings of the TWLT 15 University of Twente;213-217;1999

Schuemie M, van den Berg J. Information Retrieval Systems using an Associative Conceptual Space and Self-Organising Maps. Proceedings of the BNAIC'99 University of Maastricht;91-98;1999

Schuemie M, van den Berg J. Associative conceptual space-based information retrieval systems. Technical report 9849 Rotterdam;Erasmus University;1998

Schuemie M. Associatieve Conceptuele Ruimte: een vorm van kennisrepresentie voor informatie-zoeksystemen. Rotterdam; Erasmus University;1998